Smart-money series
Latest Politician Trades
Every disclosed Senate and House stock trade, freshest first. Click a politician for their full profile; click a filing for the original PTR.
| Date | Politician | Asset | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2025-04-21 | Bruce Westerman · R-AR | UBS · UBS Group AG Registered Ordinary Shares | Sell | $1k – $15k | — |
| 2023-07-10 | Daniel Goldman | UBS · UBS Group AG Registered Ordinary Shares | Sell | $100k – $250k | — |
| 2023-03-03 | Mikie Sherrill | UBS · UBS Group AG Registered Ordinary Shares F S: New S O: EquatePlus | Sell | $250k – $500k | — |
| 2022-05-23 | Mikie Sherrill | UBS · UBS Group AG Registered Ordinary Shares F S: New S O: Brokerage 90126 | Sell | $100k – $250k | — |
| 2021-07-27 | Katherine M. Clark · D-MA | UBS · ubS group Ag Registered Ordinary Shares | Buy | $1k – $15k | — |
| 2021-03-09 | Mikie Sherrill | UBS · uBS group Ag Registered Ordinary Shares | Sell | $250k – $500k | — |
| 2021-02-23 | John Rutherford · R-FL | UBS · uBS group Ag Registered Ordinary Shares | Sell | $1k – $15k | — |
| 2020-11-05 | Katherine M. Clark · D-MA | UBS · ubS group Ag Registered Ordinary Shares | Sell | $1k – $15k | — |
| 2020-10-22 | Katherine M. Clark · D-MA | UBS · ubS group Ag Registered Ordinary Shares | Buy | $1k – $15k | — |
| 2020-06-01 | Mikie Sherrill | UBS · UBS group Ag Registered Ordinary Shares | Sell | $50k – $100k | — |
| 2019-03-07 | Mikie Sherrill | UBS · uBS group ag Registered Ordinary Shares | Sell | $250k – $500k | — |
| 2019-01-25 | Brian Mast · R-FL | UBS · uBs group ag Registered gfedcb Ordinary shares | Sell | $15k – $50k | — |
| 2018-12-21 | Greg Gianforte | UBS · UbS Group AG Registered Ordinary Shares | Sell | $15k – $50k | — |
| 2016-07-05 | Linda T. Sanchez · D-CA | UBS · ubS group Ag Registered Ordinary Shares | Buy | $1k – $15k | — |
| 2015-01-27 | Thomas MacArthur | UBS · UBS group Ag Registered ordinary Shares | Sell | $15k – $50k | — |
Source: US House & Senate periodic transaction reports (PTRs). Educational only — not investment advice. See our methodology.